Article
Effects of CYP2D6 *10 and *41 Variants in Healthy Chinese Men on the Pharmacokinetics of Dapoxetine.
Journal of clinical pharmacology - 1 May 2024
Wang Zhipeng, Gao Yuan, Ji Xingfang, Wu Tong, Pu Libin, Qiu Wen
Abstract excerpt
Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat premature ejaculation (PE), and is mainly metabolized by CYP2D6, CYP3A4, and flavin-containing monooxygenase 1. The purpose of the study was to evaluate the effect of CYP2D6 polymorphism on the pharmacokinetics of dapoxetine in healthy Chinese men. Thirty-nine subjects who received a single oral dose of 30 mg dapoxetine hydrochloride were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
